Day One Biopharmaceuticals Holding Company, LLC IPO Research Information

Day One Biopharmaceuticals Holding Company, LLC IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Day One Biopharmaceuticals Holding Company, LLC, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Day One Biopharmaceuticals Holding Company, LLC	DAWN - NASDAQ	$14.00-$16.00	$16.00	$25.00	10 million	5/27/2021
Underwriter(s): JP Morgan, Cowen, Piper Sandler
Co-Manager(s): Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2021-05-04 Terms Added 2021-05-24 Terms Changed 2021-05-26

Day One Biopharmaceuticals Holding Company, LLC Quote & Chart - Click for current quote - DAWN

About Day One Biopharmaceuticals Holding Company, LLC (adapted from Day One Biopharmaceuticals Holding Company, LLC prospectus):
Day One was founded to address a critical unmet need: children with cancer are being left behind in a cancer drug development revolution.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "DAWN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.